• Explore /
  • Poster
  • / Trial-in-progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC).

Trial-in-progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC).

Abstract Poster

Authors

null

Hailey Kathryn Carroll

Mater Misercordiae University Hospital, Dublin, Ireland

Hailey Kathryn Carroll , Umair Aleem , Pooja Varghese , Marie Galligan , Michele Bourke , Katherine Hoey , Ronan Ryan , Peter Doran , Stephen Stewart , Cliona O'Farrelly , Tim F. Greten , Diarmaid Houlihan , Raymond S. McDermott , Austin G. Duffy

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session: Hepatobiliary Cancer

Track

Hepatobiliary Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

EudraCT Number 2019-002767-98

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr TPS355)

DOI

10.1200/JCO.2021.39.3_suppl.TPS355

Abstract #

TPS355

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Jemma Buchalter

First Author: Viktor Grünwald

First Author: Austin G. Duffy

Poster

2024 ASCO Annual Meeting

Phase 2 study of livmoniplimab in combination with budigalimab in patients with hepatocellular carcinoma.

Phase 2 study of livmoniplimab in combination with budigalimab in patients with hepatocellular carcinoma.

First Author: Ghassan K. Abou-Alfa